For instance, elevated serum PRDX6 levels have been reported in both MS and NMOSD compared to other inflammatory neurological diseases (21) and in SLE, urinary PRDX6 levels correlate with disease activity (51). This evidence concerns the gene PRDX6 and myeloid sarcoma.